Explore / Clinical trial
Clinical trial

Electrophysiologic Mechanisms of Ketamine Antidepressant Response

Emory UniversityNot yet recruitingPhase 2Started Dec 1, 202637 enrolledUnited StatesNCT07768618

Abstract

This study aims to identify electrophysiologic biomarkers associated with antidepressant response to ketamine in adults with epilepsy undergoing clinically indicated stereo-electroencephalography (sEEG) monitoring who have at least mild depressive symptoms. Participants will receive a single subanesthetic intravenous ketamine infusion (0.5 mg/kg over 40 minutes) during their Epilepsy Monitoring Unit admission. Intracranial neural recordings and behavioral assessments will be collected before and approximately 24 hours after infusion to examine changes in neural circuits associated with rumination and anhedonia.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

EpilepsyStereo-electroencephalographyAntidepressant ResponseElectrophysiologic BiomarkerEpilepsyDepressive Symptoms

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.